secwatch.observer — SEC 8-K summary
======================================

Issuer:     DarioHealth Corp. (DRIO)
CIK:        0001533998
Form:       8-K
Filed at:   2023-02-06T23:59:59+00:00
Accession:  0001104659-23-010935
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 2.04, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DarioHealth Reports Preliminary FY2022 Revenue of $27.5M and Begins Loan Repayment
--------------------------------------------------------------------------------

- Preliminary full-year 2022 total revenue expected $27.5M, up from $20.5M in 2021.
- B2B channel grew to about 60% of revenue in 2022 versus 4% in 2021.
- Operating loss reduced by more than 50% compared to Q4 2021.
- Credit agreement with OrbiMed triggers monthly repayments of up to $518,500 starting January 2023.
- Cash and equivalents at end of 2022: $49.3 million.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533998/000110465923010935/0001104659-23-010935-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533998/000110465923010935/tm235559d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-010935

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer